You are here: Home » News-CM » Companies » Results
Business Standard

Rubra Medicaments reports standalone net profit of Rs 0.01 crore in the September 2019 quarter

Capital Market 

Sales rise 55.56% to Rs 0.14 crore

Net profit of Rubra Medicaments reported to Rs 0.01 crore in the quarter ended September 2019 as against net loss of Rs 0.05 crore during the previous quarter ended September 2018. Sales rose 55.56% to Rs 0.14 crore in the quarter ended September 2019 as against Rs 0.09 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales0.140.09 56 OPM %7.14-55.56 -PBDT0.01-0.05 LP PBT0.01-0.05 LP NP0.01-0.05 LP

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, November 19 2019. 14:58 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU